Gilmore Neil O'Neill Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Gilmore Neil O'Neill is EVP, R&D & CMO of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 29,070 shares of SRPT, which is worth approximately $3.75 Million. The most recent transaction as insider was on Mar 03, 2021, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.1K

0% 3M change

0% 12M change

Total Value Held $3.75 Million

Gilmore Neil O'Neill Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 03 2021	BUY Grant, award, or other acquisition	-	15,000 Added 34.04%	29,070 Common Stock

Also insider at

UBX

Unity Biotechnology, Inc. Healthcare

APTX

Aptinyx Inc. Healthcare

EDIT

Editas Medicine, Inc. Healthcare

CEO

GNO